Impact Factor 2.635 | CiteScore 2.99
More on impact ›

Original Research ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Neurol. | doi: 10.3389/fneur.2019.01234

Use of Fatigue Index as a Measure of Local Muscle Fatigability in Ryanodine Receptor Isoform-1-Related Myopathies (RYR1-RM)

 Jessica Witherspoon1, 2*,  Julie Rekant3, Paul Wakim4, 5, Ruhi Vasavada6, Melissa Waite1, 7,  Irene C. Chrismer1, 2, Monique Shelton1, 2, Minal Jain1, 7 and  Katherine Meilleur1, 2
  • 1National Institutes of Health (NIH), United States
  • 2National Institute of Nursing Research (NINR), United States
  • 3Department of Neurobiology, University of Pittsburgh, United States
  • 4National Institutes of Health Clinical Center (NIH), United States
  • 5Other, United States
  • 6University of Central Florida College of Medicine, United States
  • 7Department of Rehabilitation Medicine, National Institutes of Health Clinical Center (NIH), United States

Introduction Individuals affected with ryanodine receptor isoform-1-related myopathies (RYR1-RM) commonly experience fatigability in the quadriceps, which may limit physical function and potentially diminish quality of life. Fatigability, in RYR1-RM, results from skeletal muscle injury secondary to dysfunction of the major skeletal muscle Ca++ channel. However, during fatigability testing, affected individuals did not always reach the point of local muscle fatigue as defined by a fatigue index (FATI) at 50% of peak torque. Surakka et al. compared three versions of FATI equations, which vary by the area under the force curve (AUC). By performing this comparison, they were able to determine the optimal equation in individuals with Multiple Sclerosis. Purpose Using a similar comparison, we sought to identify the optimal FATI equation in the RYR1-RM population. Secondly, because local muscle fatigability might have an impact on independent living, this study also assessed change in local muscle fatigability over a six-month time frame. Methods Thirty participants were analyzed from the RYR1-RM natural history study and double-blind, placebo-controlled N-acetylcysteine (NAC) trial, NCT02362425. Twenty-seven had fatigability data, from isometric knee extension and flexion fatigability tests, available for the purpose of establishing a method for predicting FATI at 50% peak torque. For the natural history study, 30 participants were used to assess disease progression of local muscle fatigability achieved during the knee extension fatigability test, and 29 participants for the knee flexion fatigability test. Results Surakka’s equation 1, using the prediction approach, led to the smallest median error, the smallest square-root of uncorrected sum of squares, and the smallest average of the absolute value of the differences. No difference was observed in FATI at 50% peak torque between month 0 and month 6 for extension (p=.606) and flexion (p=.740). Conclusion Surakka’s equation 1, with the prediction approach, was found to be the most accurate for imputing values when fatigue was not reached during a sustained knee isometric fatigability test in RYR1-RM. Furthermore, when used to assess fatigability-based disease stability, local muscle fatigability, in this RYR1-RM population remained stable.

Keywords: fatigue index, RYR1-RM, fatigability, Muscle, Neuromuscular

Received: 28 May 2019; Accepted: 06 Nov 2019.

Copyright: © 2019 Witherspoon, Rekant, Wakim, Vasavada, Waite, Chrismer, Shelton, Jain and Meilleur. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dr. Jessica Witherspoon, National Institutes of Health (NIH), Bethesda, United States, jwitherdpt.phd@gmail.com